ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995